These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 99753)

  • 1. SKF 525-A inhibition of hepatic monooxygenase activity in rhesus monkeys.
    Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 17(4):201-9. PubMed ID: 99753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High speed liquid chromatography, 14C-radioassay and spectrophotometry for measuring antipyrine plasma half-life in rhesus monkeys (Macaca mulatta).
    Clark CR; Krieger RI; Miller JL
    Pharmacology; 1978; 17(2):98-103. PubMed ID: 98774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine plasma half-life. In vivo indicator of oxidative metabolic capability in Rhesus monkeys (Macaca mulatta).
    Miller JL; Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 16(5):279-86. PubMed ID: 417345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monooxygenase-catalyzed aldrin epoxidation and dihydroisodrin hydroxylation in monkey liver needle-biopsy specimens. Assay and properties.
    Krieger RI; Gee SJ; Miller JL; Thongsinthusak
    Drug Metab Dispos; 1976; 4(1):28-34. PubMed ID: 3398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed needle liver biopsy for assessment of monooxygenase activity in rhesus monkeys (Macaca mulatta).
    Miller JL; Gee SJ; Krieger RI; Ruebner BH
    J Med Primatol; 1978; 7(1):1-7. PubMed ID: 96263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of antipyrine sulphoconjugates in isolated cultured rat hepatocytes.
    Palette C; Dubor F; Rovei V; Advenier C
    Xenobiotica; 1993 Feb; 23(2):181-91. PubMed ID: 8498081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B; Mehta S; Nain CK; Mathur VS
    Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of drug pretreatment on antipyrine elimination in the rabbit.
    Chambers DM; Jefferson GC
    Pharmacology; 1982; 24(2):88-95. PubMed ID: 7079291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-performance liquid chromatographic method for the evaluation of aldrin epoxidation by cytochrome P-450 dependent monooxygenase in small liver samples.
    Pantaleoni GC; Palumbo G; Fanini D; Giorgi R; Carlucci G; Sponta AM
    J Pharm Biomed Anal; 1989; 7(6):783-8. PubMed ID: 2490781
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Diethylaminoethyl-diphenylpropylacetate (SKF 525-A) enhancement of tissue accumulation of aldrin in mice.
    Clark CR; Krieger RI
    Toxicol Appl Pharmacol; 1976 Nov; 38(2):315-23. PubMed ID: 996862
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
    Chindavijak B; Belpaire FM; Bogaert MG
    Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cobalt chloride, SKF-525A, and N-(3,5-dichlorophenyl)succinimide on in vivo hepatic mixed function oxidase activity as determined by single-sample plasma clearances.
    Bachmann KA; Madhira MS; Rankin GO
    Xenobiotica; 1992 Jan; 22(1):27-31. PubMed ID: 1615705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A species comparison of 2,4-dinitrotoluene metabolism in vitro.
    Short RD; Dacre JC; Lee CC
    Experientia; 1979 Dec; 35(12):1625-7. PubMed ID: 118052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and metabolic effects of ethanol on rhesus monkeys.
    Ruebner BH; Krieger RI; Miller JL; Tsao M; Rorvik M
    Adv Exp Med Biol; 1975; 59():395-405. PubMed ID: 810005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.